Aptus Capital Advisors LLC Has $16.27 Million Position in Elevance Health, Inc. (NYSE:ELV)

Aptus Capital Advisors LLC raised its holdings in Elevance Health, Inc. (NYSE:ELV - Free Report) by 1,133.5% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 31,293 shares of the company's stock after purchasing an additional 28,756 shares during the period. Aptus Capital Advisors LLC's holdings in Elevance Health were worth $16,272,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. American Trust raised its holdings in shares of Elevance Health by 2.6% during the 1st quarter. American Trust now owns 775 shares of the company's stock valued at $402,000 after purchasing an additional 20 shares in the last quarter. Private Ocean LLC raised its holdings in Elevance Health by 6.7% during the second quarter. Private Ocean LLC now owns 348 shares of the company's stock valued at $189,000 after buying an additional 22 shares in the last quarter. Hurlow Wealth Management Group Inc. lifted its position in shares of Elevance Health by 1.9% in the second quarter. Hurlow Wealth Management Group Inc. now owns 1,229 shares of the company's stock worth $666,000 after buying an additional 23 shares during the last quarter. Cypress Wealth Services LLC boosted its stake in shares of Elevance Health by 3.5% during the 3rd quarter. Cypress Wealth Services LLC now owns 679 shares of the company's stock worth $353,000 after acquiring an additional 23 shares in the last quarter. Finally, CVA Family Office LLC increased its holdings in shares of Elevance Health by 4.2% during the 2nd quarter. CVA Family Office LLC now owns 602 shares of the company's stock valued at $326,000 after acquiring an additional 24 shares during the last quarter. 89.24% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Elevance Health

In other Elevance Health news, EVP Charles Morgan Kendrick, Jr. sold 7,417 shares of the business's stock in a transaction that occurred on Friday, October 18th. The stock was sold at an average price of $432.14, for a total value of $3,205,182.38. Following the sale, the executive vice president now owns 8,423 shares in the company, valued at approximately $3,639,915.22. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.35% of the company's stock.

Analysts Set New Price Targets

ELV has been the topic of a number of recent analyst reports. Wells Fargo & Company dropped their price target on shares of Elevance Health from $593.00 to $495.00 and set an "overweight" rating on the stock in a research report on Monday, November 4th. Mizuho decreased their target price on Elevance Health from $585.00 to $505.00 and set an "outperform" rating for the company in a research note on Tuesday, November 5th. Morgan Stanley dropped their price target on Elevance Health from $643.00 to $551.00 and set an "overweight" rating on the stock in a research report on Wednesday, October 23rd. Raymond James set a $485.00 price objective on Elevance Health in a research report on Friday, October 18th. Finally, TD Cowen dropped their target price on shares of Elevance Health from $589.00 to $484.00 and set a "buy" rating on the stock in a research report on Monday, October 21st. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $539.20.

Elevance Health Trading Down 2.9 %

NYSE ELV traded down $12.48 during trading hours on Tuesday, hitting $412.91. The company's stock had a trading volume of 2,029,429 shares, compared to its average volume of 1,154,130. Elevance Health, Inc. has a twelve month low of $397.98 and a twelve month high of $567.26. The firm has a market capitalization of $95.76 billion, a P/E ratio of 15.02, a PEG ratio of 1.26 and a beta of 0.85. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.56. The stock has a fifty day moving average of $486.59 and a 200 day moving average of $516.91.

Elevance Health (NYSE:ELV - Get Free Report) last issued its earnings results on Thursday, October 17th. The company reported $8.37 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $9.66 by ($1.29). The company had revenue of $44.72 billion for the quarter, compared to the consensus estimate of $43.47 billion. Elevance Health had a return on equity of 19.56% and a net margin of 3.68%. Elevance Health's quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the business posted $8.99 EPS. Equities research analysts forecast that Elevance Health, Inc. will post 32.96 earnings per share for the current fiscal year.

Elevance Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Thursday, December 5th will be given a dividend of $1.63 per share. This represents a $6.52 annualized dividend and a dividend yield of 1.58%. The ex-dividend date is Thursday, December 5th. Elevance Health's dividend payout ratio is 23.77%.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.